The application of a new nerve block in hip arthroplasty

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039976

Enrollment

Unknown

Registered

2020-11-15

Start date

2020-11-16

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip arthroplasty

Interventions

Experimental group:New nerve block

Control group:Traditional block

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective hip arthroplasty in our hospity during Sep.2020 to Sep.2021; 2. Ages 40 to 75 years; 3. ASA:I-III; 4. Subjects have volunteered to participate in the study and have signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Evidence of serious cardiovascular,renal,blood or liver disease; 2. A prior history of psychological or mental illness; 3. Contraindications to regional block technique; 4. Difficulties in communication; 5. Alcohol or drug abuse.

Design outcomes

Primary

Measure	Time frame
intraoperative sufentanil consumption;	—

Countries

China

Contacts

Public ContactGuanghong Xu

The First Affiliated Hospital of Anhui Medical University

xuguanghong2004@163.com+86 13856949535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026